Showing 13,901 - 13,920 results of 103,572 for search '(( 50 ((mean decrease) OR (nn decrease)) ) OR ( 5 ((we decrease) OR (a decrease)) ))', query time: 1.05s Refine Results
  1. 13901
  2. 13902
  3. 13903
  4. 13904
  5. 13905
  6. 13906
  7. 13907

    <i>USP28</i> protein level was decreased by hypoxia signaling via both protein degradation and transcriptional repression in A549 cells. by Qin Li (36669)

    Published 2013
    “…After treatment, cells were lysed and 50 µg of whole cell lysate was analyzed by Western blotting. …”
  8. 13908

    Longer <i>L</i><sub><i>h</i></sub> significantly decreases and delays the peak of the sound-evoked CAPs of SGN fibers. by Maral Budak (6680351)

    Published 2021
    “…<p>(A) Sound-evoked CAPs of SGN fiber populations of varying heminode length <i>L</i><sub><i>h</i></sub> at 70dB SPL, averaged over 50 simulations. Shaded regions correspond to the standard error of the mean and dashed lines correspond to the peaks of each CAP, labeled with the same colors as the CAPs. …”
  9. 13909

    Root traits dynamics. by Xinxin Chen (2031439)

    Published 2023
    “…The fluctuation of five new indicators was indicated in each sampling time, which decreased gradually with time. …”
  10. 13910

    Structure of wheat root system. by Xinxin Chen (2031439)

    Published 2023
    “…The fluctuation of five new indicators was indicated in each sampling time, which decreased gradually with time. …”
  11. 13911

    Data for Figs 4–6. by Xinxin Chen (2031439)

    Published 2023
    “…The fluctuation of five new indicators was indicated in each sampling time, which decreased gradually with time. …”
  12. 13912

    Data for Tables 1 and 2. by Xinxin Chen (2031439)

    Published 2023
    “…The fluctuation of five new indicators was indicated in each sampling time, which decreased gradually with time. …”
  13. 13913

    Fertilization and field experiment design. by Xinxin Chen (2031439)

    Published 2023
    “…The fluctuation of five new indicators was indicated in each sampling time, which decreased gradually with time. …”
  14. 13914

    Image_10_In Vitro Characterization of 177Lu-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer.t... by Tabassom Mohajershojai (9441050)

    Published 2022
    “…Moreover, the heat shock protein 90 inhibitor onalespib has previously demonstrated radiotherapy potentiation effects in vivo. In the present study, a <sup>177</sup>Lu-radiolabeled anti-CEA hT84.66-M5A mAb (M5A) conjugate was developed and the potential therapeutic effects of <sup>177</sup>Lu-DOTA-M5A and/or onalespib were investigated. …”
  15. 13915

    Image_1_In Vitro Characterization of 177Lu-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer.ti... by Tabassom Mohajershojai (9441050)

    Published 2022
    “…Moreover, the heat shock protein 90 inhibitor onalespib has previously demonstrated radiotherapy potentiation effects in vivo. In the present study, a <sup>177</sup>Lu-radiolabeled anti-CEA hT84.66-M5A mAb (M5A) conjugate was developed and the potential therapeutic effects of <sup>177</sup>Lu-DOTA-M5A and/or onalespib were investigated. …”
  16. 13916

    Image_4_In Vitro Characterization of 177Lu-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer.ti... by Tabassom Mohajershojai (9441050)

    Published 2022
    “…Moreover, the heat shock protein 90 inhibitor onalespib has previously demonstrated radiotherapy potentiation effects in vivo. In the present study, a <sup>177</sup>Lu-radiolabeled anti-CEA hT84.66-M5A mAb (M5A) conjugate was developed and the potential therapeutic effects of <sup>177</sup>Lu-DOTA-M5A and/or onalespib were investigated. …”
  17. 13917

    Image_3_In Vitro Characterization of 177Lu-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer.ti... by Tabassom Mohajershojai (9441050)

    Published 2022
    “…Moreover, the heat shock protein 90 inhibitor onalespib has previously demonstrated radiotherapy potentiation effects in vivo. In the present study, a <sup>177</sup>Lu-radiolabeled anti-CEA hT84.66-M5A mAb (M5A) conjugate was developed and the potential therapeutic effects of <sup>177</sup>Lu-DOTA-M5A and/or onalespib were investigated. …”
  18. 13918

    Image_8_In Vitro Characterization of 177Lu-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer.ti... by Tabassom Mohajershojai (9441050)

    Published 2022
    “…Moreover, the heat shock protein 90 inhibitor onalespib has previously demonstrated radiotherapy potentiation effects in vivo. In the present study, a <sup>177</sup>Lu-radiolabeled anti-CEA hT84.66-M5A mAb (M5A) conjugate was developed and the potential therapeutic effects of <sup>177</sup>Lu-DOTA-M5A and/or onalespib were investigated. …”
  19. 13919

    Image_6_In Vitro Characterization of 177Lu-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer.ti... by Tabassom Mohajershojai (9441050)

    Published 2022
    “…Moreover, the heat shock protein 90 inhibitor onalespib has previously demonstrated radiotherapy potentiation effects in vivo. In the present study, a <sup>177</sup>Lu-radiolabeled anti-CEA hT84.66-M5A mAb (M5A) conjugate was developed and the potential therapeutic effects of <sup>177</sup>Lu-DOTA-M5A and/or onalespib were investigated. …”
  20. 13920

    Image_9_In Vitro Characterization of 177Lu-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer.ti... by Tabassom Mohajershojai (9441050)

    Published 2022
    “…Moreover, the heat shock protein 90 inhibitor onalespib has previously demonstrated radiotherapy potentiation effects in vivo. In the present study, a <sup>177</sup>Lu-radiolabeled anti-CEA hT84.66-M5A mAb (M5A) conjugate was developed and the potential therapeutic effects of <sup>177</sup>Lu-DOTA-M5A and/or onalespib were investigated. …”